Filing Details
ESCALON MEDICAL CORP (OTC:ESMC) filed its annual report (Form 10-K) with the Securities and Exchange Commission on October 13, 2026.
The Healthcare company's annual report covers fiscal year 2026.
10k filedOTC:ESMC
ESCALON MEDICAL CORP (ESMC) Files Annual Report with SEC
ESCALON MEDICAL CORP (OTC:ESMC) filed its annual report (Form 10-K) with the Securities and Exchange Commission on October 13, 2026.
At publication ·
What changed
ESCALON MEDICAL CORP (OTC:ESMC) · 10k filed
- Form
- 10-K
At a glance
Key takeaways
- Escalon Medical Corp filed its 2026 annual report (Form 10-K) with the SEC on October 13, 2026.
- The healthcare company's stock trades at $0.17 with a market capitalization of $1.2 million.
- The 10-K filing contains detailed financial statements, management analysis, risk factors, and business segment information for the full fiscal year.
Market Context
ESCALON MEDICAL CORP's stock currently trades at $0.17 with a market capitalization of $1.2M.
The 10-K is the most comprehensive annual report a public company files, containing detailed financial statements, management discussion and analysis (MD&A), risk factors, and business segment breakdowns. For ESCALON MEDICAL CORP investors, the 10-K provides depth that quarterly reports don't — including full-year trends, long-term debt schedules, and off-balance-sheet items.
Key sections to review: MD&A for management's narrative on performance, risk factors for newly disclosed threats, and the notes to financial statements for accounting changes that could affect reported earnings.
All SEC filings for ESCALON MEDICAL CORP are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ESMC Stock Page
Frequently Asked Questions
Where can I read ESMC's SEC filings?
Browse all filings on our ESMC SEC filings page.
What types of SEC filings does ESCALON MEDICAL CORP file?
Public companies like ESCALON MEDICAL CORP file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.